Efficacy and immunogenicity of Mycobacterium bovis ΔRD1 against aerosol M. bovis infection in neonatal calves

W. Ray Waters; Mitchell V. Palmer; Brian J. Nonnecke; Tyler C. Thacker; Charles F.Capinos Scherer; D. Mark Estes; R. Glyn Hewinson; H. Martin Vordermeier; S. Whitney Barnes; Glenn C. Federe; John R. Walker; Richard J. Glynne; Tsungda Hsu; Brian Weinrick; Karolin Biermann; Michelle H. Larsen; William R. Jacobs

doi:10.1016/j.vaccine.2008.12.018

Efficacy and immunogenicity of Mycobacterium bovis ΔRD1 against aerosol M. bovis infection in neonatal calves

W. Ray Waters^*, Mitchell V. Palmer, Brian J. Nonnecke, Tyler C. Thacker, Charles F.Capinos Scherer, D. Mark Estes, R. Glyn Hewinson, H. Martin Vordermeier, S. Whitney Barnes, Glenn C. Federe, John R. Walker, Richard J. Glynne, Tsungda Hsu, Brian Weinrick, Karolin Biermann, Michelle H. Larsen, William R. Jacobs

^*Awdur cyfatebol y gwaith hwn

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

Crynodeb

An attenuated Mycobacterium bovis RD1 deletion (ΔRD1) mutant of the Ravenel strain was constructed, characterized, and sequenced. This M. bovis ΔRD1 vaccine strain administered to calves at 2 weeks of age provided similar efficacy as M. bovis bacillus Calmette Guerin (BCG) against low dose, aerosol challenge with virulent M. bovis at 3.5 months of age. Approximately 4.5 months after challenge, both ΔRD1- and BCG-vaccinates had reduced tuberculosis (TB)-associated pathology in lungs and lung-associated lymph nodes and M. bovis colonization of tracheobronchial lymph nodes as compared to non-vaccinates. Mean central memory responses elicited by either ΔRD1 or BCG prior to challenge correlated with reduced pathology and bacterial colonization. Neither ΔRD1 or BCG elicited IFN-γ responses to rESAT-6:CFP-10 prior to challenge, an emerging tool for modern TB surveillance programs. The ΔRD1 strain may prove useful for bovine TB vaccine programs, particularly if additional mutations are included to improve safety and immunogenicity.

Iaith wreiddiol	Saesneg
Tudalennau (o-i)	1201-1209
Nifer y tudalennau	9
Cyfnodolyn	Vaccine
Cyfrol	27
Rhif cyhoeddi	8
Dyddiad ar-lein cynnar	09 Ion 2009
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.1016/j.vaccine.2008.12.018
Statws	Cyhoeddwyd - 18 Chwef 2009

NDC y CU

Mae’r allbwn hwn yn cyfrannu at y Nod(au) Datblygu Cynaliadwy canlynol

Mynediad at Ddogfen

10.1016/j.vaccine.2008.12.018

Cysylltiad parhaol

Dolen barhaus

Ffeiliau eraill a chysylltiadau

Link to publication in Scopus

Dyfynnu hyn

Waters, W. R., Palmer, M. V., Nonnecke, B. J., Thacker, T. C., Scherer, C. F. C., Estes, D. M., Hewinson, R. G., Vordermeier, H. M., Barnes, S. W., Federe, G. C., Walker, J. R., Glynne, R. J., Hsu, T., Weinrick, B., Biermann, K., Larsen, M. H., & Jacobs, W. R. (2009). Efficacy and immunogenicity of Mycobacterium bovis ΔRD1 against aerosol M. bovis infection in neonatal calves. Vaccine, 27(8), 1201-1209. https://doi.org/10.1016/j.vaccine.2008.12.018

@article{74f95fd1956c4f1596b4022357d8b868,

title = "Efficacy and immunogenicity of Mycobacterium bovis ΔRD1 against aerosol M. bovis infection in neonatal calves",

abstract = "An attenuated Mycobacterium bovis RD1 deletion (ΔRD1) mutant of the Ravenel strain was constructed, characterized, and sequenced. This M. bovis ΔRD1 vaccine strain administered to calves at 2 weeks of age provided similar efficacy as M. bovis bacillus Calmette Guerin (BCG) against low dose, aerosol challenge with virulent M. bovis at 3.5 months of age. Approximately 4.5 months after challenge, both ΔRD1- and BCG-vaccinates had reduced tuberculosis (TB)-associated pathology in lungs and lung-associated lymph nodes and M. bovis colonization of tracheobronchial lymph nodes as compared to non-vaccinates. Mean central memory responses elicited by either ΔRD1 or BCG prior to challenge correlated with reduced pathology and bacterial colonization. Neither ΔRD1 or BCG elicited IFN-γ responses to rESAT-6:CFP-10 prior to challenge, an emerging tool for modern TB surveillance programs. The ΔRD1 strain may prove useful for bovine TB vaccine programs, particularly if additional mutations are included to improve safety and immunogenicity.",

keywords = "Aerosol inoculation, BCG, Live bacterial vaccine, Neonatal calf, RD1, Tuberculosis",

author = "Waters, {W. Ray} and Palmer, {Mitchell V.} and Nonnecke, {Brian J.} and Thacker, {Tyler C.} and Scherer, {Charles F.Capinos} and Estes, {D. Mark} and Hewinson, {R. Glyn} and Vordermeier, {H. Martin} and Barnes, {S. Whitney} and Federe, {Glenn C.} and Walker, {John R.} and Glynne, {Richard J.} and Tsungda Hsu and Brian Weinrick and Karolin Biermann and Larsen, {Michelle H.} and Jacobs, {William R.}",

year = "2009",

month = feb,

day = "18",

doi = "10.1016/j.vaccine.2008.12.018",

language = "English",

volume = "27",

pages = "1201--1209",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier",

number = "8",

}

Waters, WR, Palmer, MV, Nonnecke, BJ, Thacker, TC, Scherer, CFC, Estes, DM, Hewinson, RG, Vordermeier, HM, Barnes, SW, Federe, GC, Walker, JR, Glynne, RJ, Hsu, T, Weinrick, B, Biermann, K, Larsen, MH & Jacobs, WR 2009, 'Efficacy and immunogenicity of Mycobacterium bovis ΔRD1 against aerosol M. bovis infection in neonatal calves', Vaccine, cyfrol. 27, rhif 8, tt. 1201-1209. https://doi.org/10.1016/j.vaccine.2008.12.018

TY - JOUR

T1 - Efficacy and immunogenicity of Mycobacterium bovis ΔRD1 against aerosol M. bovis infection in neonatal calves

AU - Waters, W. Ray

AU - Palmer, Mitchell V.

AU - Nonnecke, Brian J.

AU - Thacker, Tyler C.

AU - Scherer, Charles F.Capinos

AU - Estes, D. Mark

AU - Hewinson, R. Glyn

AU - Vordermeier, H. Martin

AU - Barnes, S. Whitney

AU - Federe, Glenn C.

AU - Walker, John R.

AU - Glynne, Richard J.

AU - Hsu, Tsungda

AU - Weinrick, Brian

AU - Biermann, Karolin

AU - Larsen, Michelle H.

AU - Jacobs, William R.

PY - 2009/2/18

Y1 - 2009/2/18

N2 - An attenuated Mycobacterium bovis RD1 deletion (ΔRD1) mutant of the Ravenel strain was constructed, characterized, and sequenced. This M. bovis ΔRD1 vaccine strain administered to calves at 2 weeks of age provided similar efficacy as M. bovis bacillus Calmette Guerin (BCG) against low dose, aerosol challenge with virulent M. bovis at 3.5 months of age. Approximately 4.5 months after challenge, both ΔRD1- and BCG-vaccinates had reduced tuberculosis (TB)-associated pathology in lungs and lung-associated lymph nodes and M. bovis colonization of tracheobronchial lymph nodes as compared to non-vaccinates. Mean central memory responses elicited by either ΔRD1 or BCG prior to challenge correlated with reduced pathology and bacterial colonization. Neither ΔRD1 or BCG elicited IFN-γ responses to rESAT-6:CFP-10 prior to challenge, an emerging tool for modern TB surveillance programs. The ΔRD1 strain may prove useful for bovine TB vaccine programs, particularly if additional mutations are included to improve safety and immunogenicity.

AB - An attenuated Mycobacterium bovis RD1 deletion (ΔRD1) mutant of the Ravenel strain was constructed, characterized, and sequenced. This M. bovis ΔRD1 vaccine strain administered to calves at 2 weeks of age provided similar efficacy as M. bovis bacillus Calmette Guerin (BCG) against low dose, aerosol challenge with virulent M. bovis at 3.5 months of age. Approximately 4.5 months after challenge, both ΔRD1- and BCG-vaccinates had reduced tuberculosis (TB)-associated pathology in lungs and lung-associated lymph nodes and M. bovis colonization of tracheobronchial lymph nodes as compared to non-vaccinates. Mean central memory responses elicited by either ΔRD1 or BCG prior to challenge correlated with reduced pathology and bacterial colonization. Neither ΔRD1 or BCG elicited IFN-γ responses to rESAT-6:CFP-10 prior to challenge, an emerging tool for modern TB surveillance programs. The ΔRD1 strain may prove useful for bovine TB vaccine programs, particularly if additional mutations are included to improve safety and immunogenicity.

KW - Aerosol inoculation

KW - BCG

KW - Live bacterial vaccine

KW - Neonatal calf

KW - RD1

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=59049107925&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2008.12.018

DO - 10.1016/j.vaccine.2008.12.018

M3 - Article

C2 - 19135497

AN - SCOPUS:59049107925

SN - 0264-410X

VL - 27

SP - 1201

EP - 1209

JO - Vaccine

JF - Vaccine

IS - 8

ER -

Efficacy and immunogenicity of Mycobacterium bovis ΔRD1 against aerosol M. bovis infection in neonatal calves

Crynodeb

NDC y CU

Mynediad at Ddogfen

Cysylltiad parhaol

Ffeiliau eraill a chysylltiadau

Ôl bys

Dyfynnu hyn